Alzheimer’s drug Kisunla approved for early-stage treatment in...
Australia has approved a new drug to treat early-stage Alzheimer’s disease, with Kisunla (donanemab) now available for prescription by specialists following registration by the Therapeutic Goods Administration (TGA). Developed by Eli Lilly, Kisunla is …